Skip to main content

Continental Advisors LLC

SEC CIK
0001277779
Latest filing
Jul 27, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by Continental Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
232,118
Value
$7.86M
% of portfolio
4.6%
Quarters held
22
Since Q1 2021
Holdings of TEVA by Continental Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026232,118$7.86M4.6%−10,000−4.1%ReducedHolders
Q1 2026242,118$7.29M4.5%−46,000−16.0%ReducedHolders
Q4 2025288,118$8.99M5.8%−53,000−15.5%ReducedHolders
Q3 2025341,118$6.89M4.7%00.0%UnchangedHolders
Q2 2025341,118$5.72M4.1%00.0%UnchangedHolders
Q1 2025341,118$5.24M3.9%00.0%UnchangedHolders
Q4 2024341,118$7.52M5.7%−20,500−5.7%ReducedHolders
Q3 2024361,618$6.52M4.8%−42,148−10.4%ReducedHolders
Q2 2024403,766$6.56M5.1%−74,000−15.5%ReducedHolders
Q1 2024477,766$6.74M5.3%+162,900+51.7%AddedHolders
Q4 2023314,866$3.29M3.0%−26,000−7.6%ReducedHolders
Q3 2023340,866$3.48M3.1%−72,500−17.5%ReducedHolders
Q2 2023413,366$3.11M2.7%+43,566+11.8%AddedHolders
Q1 2023369,800$3.27M3.0%+63,500+20.7%AddedHolders
Q4 2022306,300$2.79M2.6%+131,000+74.7%AddedHolders
Q3 2022175,300$1.42M1.3%−78,186−30.8%ReducedHolders
Q2 2022253,486$1.91M1.7%−25,000−9.0%ReducedHolders
Q1 2022278,486$2.62M2.2%−10,000−3.5%ReducedHolders
Q4 2021288,486$2.31M1.8%00.0%UnchangedHolders
Q3 2021288,486$2.81M2.0%+29,000+11.2%AddedHolders
Q2 2021259,486$2.57M1.8%+10,000+4.0%AddedHolders
Q1 2021249,486$2.88M2.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.